← Muscle Growth & Body Composition

Tesamorelin

A stabilized GHRH analog. It signals the pituitary to release growth hormone, which preferentially reduces visceral (deep abdominal) fat.

Choose your dose

Checking your status…

Tesamorelin costs more than most peptides because each dose uses a lot of it. You choose the dose and your prescriber reviews it. 2 mg is the dose the trials that reduced visceral fat used. A 2 mg fill here is two vials: 24 doses, about 4.8 weeks. About 1 mg has been studied for other goals. A fill is one vial: 23 doses, about 4.6 weeks. 0.75 mg comes from the smaller 3 mg/mL vial; the trials cited below used 1 mg and 2 mg. A fill is one vial: 20 doses, 4 weeks. All three are taken at bedtime Monday to Friday, at pharmacy cost. The brand-name version, Egrifta WR, runs about $10,700 cash for a 28-day supply. Sources are listed in the protocol section below.

Pricing is what the pharmacy charges for the medication, per vial, with nothing added. Each order also carries the $39 prescriber review.

Tesamorelin High-Dose 24 mg / 3 mL injectable vial compounded by a licensed U.S. 503A compounding pharmacy for Rx Peps Direct

Verify us before you order

Visceral Fat ReductionPhase III DoseClinically StudiedBody Composition

What It Is

Tesamorelin is a GHRH analog with Phase III trial data for reducing visceral fat. The brand-name version, Egrifta, is FDA approved. Ours is compounded by a licensed U.S. 503A compounding pharmacy at 24 mg in 3 mL (8 mg/mL) and at 15 mg in 5 mL (3 mg/mL). You choose 0.75 mg (one 3 mg/mL vial a fill), about 1 mg (one 8 mg/mL vial a fill) or 2 mg (two 8 mg/mL vials a fill) when you order, and your prescriber reviews it. The label states the units for the vial you have.

How It Works

It stimulates the pituitary to release growth hormone, which targets visceral fat stores. In the Phase III trial, 2 mg a day, seven days a week, cut visceral fat by 15 percent at 26 weeks and 18 percent at 52 weeks with continued use. We run 2 mg Monday to Friday, about 71 percent of the trial's weekly amount, so results may be smaller in proportion. The lower doses, about 1 mg and 0.75 mg, have not been tested for visceral fat.

Who It's For

Adults with excess visceral (belly) fat who can commit to at least 26 weeks and will measure their waist before the first dose, at week 12, and at week 26.

Who Should Avoid It

Not for active cancer, a pituitary tumor, or pregnancy. Prohibited at all times in tested sport (WADA). Tell your prescriber about diabetes or prediabetes, carpal tunnel symptoms, or joint problems. If you have diabetes or prediabetes, send a recent HbA1c or fasting glucose from your own doctor before your first fill.

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.


Protocol & Pricing

Pharmacy Price

$200

8mg/mL, 3mL vial (24mg total)

You pay pharmacy price. No markup.

0.75 mg is 1 vial a fill of the 3 mg/mL strength ($100), 20 doses, 4 weeks. About 1 mg is 1 vial a fill ($200), 23 doses, about 4.6 weeks. 2 mg is 2 vials a fill ($400), 24 doses, about 4.8 weeks.

Starting Dose

0.75 mg (25 units of the 3 mg/mL vial), about 1 mg (13 units) or 2 mg (25 units) of the 8 mg/mL vial, at bedtime, Monday to Friday

Form

Injectable vial, 3mL


Your pharmacy label will read

TESAMORELIN

8 MG/ML (3 ML)

The label shows strength per mL, not the total in the vial.

What that means

  • 8mg/mL means 8mg in every mL.
  • The vial holds 3mL, so 8mg/mL × 3mL = 24mg in the vial.
  • Each 25-unit injection (0.25mL) gives you 2mg, about 12 injections per vial.

Dosing Protocol

You choose the dose when you order, and your prescriber reviews it. 0.75 mg is 25 units (0.25 mL) of the 3 mg/mL vial: 25 units x 3 mg/mL = 0.75 mg per injection, 1 vial a fill (20 doses, 4 weeks). About 1 mg is 13 units (0.13 mL) of the 8 mg/mL vial: 13 units x 8 mg/mL = 1.04 mg per injection, 1 vial a fill (23 doses, about 4.6 weeks). 2 mg is 25 units (0.25 mL) of the same vial: 25 units x 8 mg/mL = 2 mg per injection, 2 vials a fill (24 doses, about 4.8 weeks). 2 mg is the dose the Phase III visceral fat results came from. Inject under the skin of the abdomen at bedtime, Monday to Friday, with two days off each week. Your prescriber can also set about 1 mg on the 3 mg/mL vial, which is 33 units. Tesamorelin comes in those two strengths and they are not interchangeable, so check the concentration on the label before every draw: 25 units of the 8 mg/mL vial is 2 mg, and 25 units of the 3 mg/mL vial is 0.75 mg. Run it for at least 26 weeks.

Beyond Use Date

90 Days from compounding (USP <797>)

A licensed U.S. 503A compounding pharmacy assigns this date and prints it on your vial label. Always follow the label.

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.


How the tesamorelin protocol works

You choose between three doses: 0.75 mg, about 1 mg, or 2 mg, the dose the Phase III trials used. Your prescriber reviews and approves every fill.

0.75 mg25 units of the 3 mg/mL vial (15 mg in 5 mL), one vial a fill. None of the trials cited below used this dose.
About 1 mg13 units of the 8 mg/mL vial (24 mg in 3 mL), one vial a fill. Studied for other goals than visceral fat.
2 mg25 units of the same vial, two vials a fill. The dose the visceral fat results came from.
Your choiceYou pick the dose when you order, and your prescriber reviews it. No dose is a step toward another.
Another vialYour prescriber can also set about 1 mg on a different vial: 33 units of the 3 mg/mL vial (15 mg in 5 mL). That one is not something you choose at checkout. The label states the units for the vial you have.
Check the labelThe two strengths are not interchangeable. Check the concentration on the label before every draw: 25 units of the 8 mg/mL vial is 2 mg; 25 units of the 3 mg/mL vial is 0.75 mg. So 0.75 mg and 2 mg are both 25 units, on different vials.
WhenOnce at bedtime, Monday to Friday, two days off each week.
HowUnder the skin of the abdomen, rotating sites, with a U-100 insulin syringe. A 0.3 mL barrel reads a draw of up to 30 units most accurately. A 33-unit draw is more than a 0.3 mL barrel holds, so it needs a larger U-100 syringe.
How longAt least 26 weeks. Your prescriber reviews whether to continue.

Why we run it this way

  • 2 mg is the dose the visceral fat results came from. In the Phase III trial, 2 mg a day cut visceral fat by 15 percent at 26 weeks [Falutz 2007, NEJM], and by 18 percent at 52 weeks in people who kept taking it [Falutz 2008, AIDS]. Those trials enrolled adults with HIV-related belly fat, the only group the brand is approved for. No lower dose has been tested for visceral fat.
  • What about 1 mg has been studied for. In a 20-week trial in adults 55 to 87, 1 mg nightly lowered body fat by 7.4 percent [Baker 2012, Arch Neurol]. That trial did not measure visceral fat. If visceral fat is your goal, 2 mg is the dose with the evidence.
  • Why five days a week, not seven. The pharmacy sends at most two vials per fill. Two vials hold 24 doses. On a five-day week that lasts almost five weeks; on a seven-day week it would run out in 24 days. Five days a week gives you about 71 percent of the trial's weekly amount, so results may be smaller in proportion. We state that plainly rather than hide it.
  • Two strengths, and the same unit mark is a different dose on each. Tesamorelin comes as a 8 mg/mL vial and a 3 mg/mL vial. 25 units of the 8 mg/mL vial is 2 mg; 25 units of the 3 mg/mL vial is 0.75 mg. Check the concentration on the label before every draw, and draw the units printed on that vial's label.
  • Why no routine ramp-up. Neither the approved label nor the trials titrate [Egrifta WR label], so there is no dose you have to pass through first: you can start on any of them. Your prescriber can lower the dose: for a two-week tolerance start, for side effects, or for older or smaller patients and those with diabetes.
  • Why bedtime. It lines up with the natural growth hormone pulse during deep sleep. The trials allowed any time of day, so consistency matters more than the exact hour.

What it costs, and why

Tesamorelin is a long peptide, 44 amino acids, and a 2 mg dose is more than three times the amount in a sermorelin dose. The milligrams are what you pay for, which is why about 1 mg costs about half what 2 mg does. About 1 mg is not the dose the visceral fat results came from.

For comparison, the brand-name version, Egrifta WR, lists at about $10,700 cash for one 28-day package [Drugs.com, checked 29 Sep 2026] [package size: Egrifta WR label]. Egrifta is the FDA-approved product. Ours is compounded by a 503A pharmacy; it is not Egrifta and has not been reviewed by the FDA. At pharmacy cost, 2 mg runs $400 for about 4.8 weeks, about 1 mg runs $200 for about 4.6 weeks, and 0.75 mg runs $100 for 4 weeks.

0.75 mg (25 units)About 1 mg (13 units)2 mg (25 units)About 1 mg, 3 mg/mL vial (33 units). Prescriber only
Vial15 mg, 3 mg/mL24 mg, 8 mg/mL24 mg, 8 mg/mL15 mg, 3 mg/mL
Doses per vial20231215
Vials per fill1121
Pharmacy cost per fill$100$200$400$100
One fill lasts4 weeks (20 doses)about 4.6 weeks (23 doses)about 4.8 weeks (24 doses)3 weeks (15 doses)
Cost per week$25about $43about $83about $33
26-week course (pharmacy)7 vials, $7006 vials, $1,20011 vials, $2,2009 vials, $900

The 33-unit dose on the 3 mg/mL vial is set by your prescriber only. The label states the units for the vial you have.

Each order also carries the $39 prescriber review. Pharmacy prices are the pharmacy's own; we add nothing to them.


What to expect

Weeks 1 to 2Deeper sleep, easier mornings. No measurable fat change yet.
Weeks 8 to 12Earliest change in waist size, in people who respond.
Week 26The window where the trials measured their result. Not everyone responds: the trials counted a response as at least an 8 percent drop in visceral fat [Stanley 2012], and the brand label tells doctors to consider stopping when there is no clear response. If your waist has not changed by week 26, your prescriber will talk with you about stopping.
After 12 monthsStopping lets visceral fat return [Falutz 2008]. Your prescriber decides with you whether to continue.

Measure your waist at your belly button before your first dose, at week 12, and at week 26. That measurement is how we judge whether it is working.


Storage

Keep vials in the refrigerator (36 to 46 °F), away from light, never frozen.


Who should not use it

Active cancer, a pituitary tumor, pregnancy. Prohibited at all times in tested sport (WADA). Tell your prescriber about diabetes or prediabetes, carpal tunnel symptoms, or joint problems.

If you have diabetes or prediabetes, send a recent HbA1c or fasting glucose from your own doctor before your first fill. We do not order lab work. Everyone else starts without a test.

Side effects to tell your prescriber about

Joint pain, swelling in the hands or feet, tingling or numbness in the hands, rising home glucose readings, injection-site redness. Message your provider in the portal. These usually mean the dose should come down, not that the drug should stop. Your prescriber can lower the dose, and the label states the units for the vial you have. Do not change the dose yourself.


Studies and sources


Why this dose, and what the evidence shows

From our medical director's protocol for Tesamorelin High-Dose. Where the evidence is thin, it says so.

Why this dose

Tesamorelin has extensive human clinical research and FDA-approved medical use.

The 2 mg dose was used in major clinical trials evaluating reductions in visceral abdominal fat in adults with HIV-associated lipodystrophy.

Lower doses have also been studied for other metabolic and endocrine outcomes.

The protocol dose should therefore be selected around the treatment goal and individual clinical considerations.


What the evidence shows

Tesamorelin stimulates growth hormone release and increases IGF-1 through the body's growth-hormone axis.

Large randomized human trials showed reductions in visceral abdominal fat in adults with HIV-associated lipodystrophy.

Those results provide strong evidence for tesamorelin's biological effect on visceral fat in the population studied.

The same studies do not establish equivalent results in otherwise healthy adults seeking general body-composition changes.

Tesamorelin therefore has strong human evidence as a medication, while use outside its studied and approved patient population requires greater extrapolation.

Each order also carries the $39 prescriber review. Pharmacy prices are the pharmacy's own; we add nothing to them.

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.


Stacking Guide

Stacks Well With

BPC-157

Do Not Combine With

Tesamorelin/IpamorelinLean Stack (SS-31/MOTs-C/Tesamorelin)

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.


GHRH analog (Egrifta is the FDA-approved brand)

Read the Tesamorelin protocol guide

The only GHRH analog with Phase III trials behind an FDA-approved brand. The 2 mg protocol, how a response is judged, and what returns when you stop.

Read guide

Related Peptides


Independently tested

Tesamorelin High-Dose certificate of analysis

All 2 Tesamorelin High-Dose samples tested for sterility and endotoxin passed both. Latest sample received by the lab Sep 29, 2026.

Every Tesamorelin High-Dose batch dispensed by a licensed U.S. 503A compounding pharmacy is independently tested by Eagle Analytical Services (FDA-registered, A2LA ISO 17025 accredited). Sterility testing checks that nothing grows in the sample; the USP <85> endotoxin test checks for bacterial toxins that can cause fever. Below is the lab's own report for each of the 2 most recent lots.

Lot LG342010961, received Sep 29, 2026

Sterility
PassCelsis Sterility Test. Started Sep 29, 2026, completed Oct 7, 2026. Method suitability ETX-250826-0390
Bacterial endotoxin
PassUSP <85>. Measured <2 EU/mL, limit 1750 EU/mL. Started Oct 1, 2026, completed Oct 1, 2026
Sample, as printed
TESAMORELIN 8 MG/ML (3 ML) Injection
Lot #
LG342010961
Storage
Refrigerated
Received by lab
Sep 29, 2026
Laboratory
Eagle Analytical Services Inc., Houston, TX
Submission #
ETX-260929-0818
Signed
Alison Eng, Quality Control Manager
Scan of Eagle Analytical report ETX-260929-0818 for lot LG342010961. Opens the original PDF.
Eagle Analytical report ETX-260929-0818. Open the original PDF (opens in a new tab)

Eagle Analytical Services is an independent FDA-registered laboratory, A2LA accredited to ISO 17025, based in Houston, Texas. They have no commercial relationship with Rx Peps Direct. Rx Peps Direct prescribes; the pharmacy compounds and dispenses; Eagle tests every batch. Three separate companies. Results apply only to the tested sample as received. Browse our full quality program on the quality page.

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.


How to get Tesamorelin High-Dose prescribed online

Tesamorelin High-Dose is available by prescription after an online medical review and dispensed for human use by a licensed 503A pharmacy. That is what separates it from research-use-only vials sold without a prescription. There is no membership, just a medical review fee per order, and automatic refills are optional.

  1. 1

    Complete a $39 medical review. Answer a short intake about your health history and your goals for Tesamorelin High-Dose. The $39 fee is the only charge Rx Peps Direct collects, paid once, not a recurring subscription.

  2. 2

    A licensed provider reviews it. A US-licensed clinician reviews your intake and, if Tesamorelin High-Dose is appropriate for you, writes a patient-specific prescription. The starting dose is typically 0.75 mg (25 units of the 3 mg/mL vial), about 1 mg (13 units) or 2 mg (25 units) of the 8 mg/mL vial, at bedtime, Monday to Friday.

  3. 3

    The pharmacy compounds and ships it. A licensed 503A compounding pharmacy in Texas compounds Tesamorelin High-Dose and ships it pre-reconstituted by FedEx overnight in a reusable cooled case. Your fill is a 3mL injectable vial at 8mg/mL (24mg total), labeled "TESAMORELIN 8 MG/ML (3 ML)", and you pay the pharmacy $200 per vial at wholesale, with no clinic markup, plus a $15 flat FedEx overnight shipping fee charged by the pharmacy.

Rx Peps Direct prescribes Tesamorelin High-Dose in the 28 states plus Washington, DC where its medical team is licensed. Start your $39 medical review or browse the full Muscle Growth & Body Composition range. Comparing services first? See how Rx Peps Direct stacks up against seven other providers in our best telehealth for compounded peptides comparison.

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.


Common questions about Tesamorelin High-Dose

What is tesamorelin?
Tesamorelin is a 44-amino acid GHRH analog with a longer half-life than sermorelin. It binds GHRH receptors at the pituitary and stimulates endogenous growth hormone release. The molecule is FDA-approved as Egrifta for the reduction of excess abdominal fat in adults with HIV-associated lipodystrophy. It is also used off-label in age-management practices for body composition and visceral fat reduction.
Is tesamorelin FDA-approved?
Tesamorelin was FDA-approved as the branded product Egrifta for HIV-associated lipodystrophy. The tesamorelin Rx Peps Direct prescribes is not that branded product: the pharmacy compounds it under Section 503A of the Federal Food, Drug, and Cosmetic Act as a patient-specific prescription, which is legal but is a different regulatory pathway than FDA approval of the specific compounded preparation. Off-label use for visceral adiposity in non-HIV patients is permissible under physician judgment. Rx Peps Direct providers prescribe tesamorelin within their state's scope of practice.
How is tesamorelin dosed at Rx Peps Direct?
You choose between three doses when you order, all taken once at bedtime Monday to Friday with two days off each week. 2 mg is 25 units (0.25 mL) of the 8 mg/mL vial (Tesamorelin High-Dose, 24 mg in 3 mL), two vials a fill. That is the dose the Phase III visceral fat results came from. About 1 mg is 13 units (0.13 mL) of the same vial, one vial a fill. 0.75 mg is 25 units (0.25 mL) of the 3 mg/mL vial (15 mg in 5 mL), one vial a fill. Neither lower dose has been tested for visceral fat. Neither the approved label nor the trials titrate, so you can start on any of them, and your prescriber reviews the dose you choose. Your prescriber can lower the dose: for a two-week tolerance start, for side effects, or for older or smaller patients and those with diabetes. Your prescriber can also set about 1 mg on the 3 mg/mL vial (15 mg in 5 mL), which is 33 units and is not something you choose at checkout. The label states the units for the vial you have. Tesamorelin comes in those two strengths and they are not interchangeable, so check the concentration on the label before every draw: 25 units of the 8 mg/mL vial is 2 mg, and 25 units of the 3 mg/mL vial is 0.75 mg. Plan on at least 26 weeks, then your prescriber reviews whether to continue.
Why Monday to Friday instead of every day?
The pharmacy sends at most two vials per fill, and two vials hold 24 doses at 2 mg. On a five-day week that lasts almost five weeks; on a seven-day week it would run out in 24 days. Five days a week gives you about 71 percent of the trial's weekly amount, so results may be smaller in proportion. We state that plainly rather than hide it.
How much does tesamorelin cost?
The High-Dose vial is $200 at the pharmacy's price, with nothing added. At 2 mg a vial holds 12 doses and a fill is 2 vials ($400), which lasts about 4.8 weeks, or about $83 a week. A 26-week course is 11 vials, $2,200. At about 1 mg a fill is 1 vial ($200): 23 doses at 13 units, about 4.6 weeks, about $43 a week, and 6 vials ($1,200) over 26 weeks. If your prescriber sets about 1 mg on the 15 mg vial (3 mg/mL, $100), a fill is 1 vial of 15 doses: 3 weeks, about $33 a week, and 9 vials ($900) over 26 weeks. Each order also carries the $39 prescriber review.
How do I know if tesamorelin is working?
Measure your waist at your belly button before your first dose, at week 12, and at week 26. Sleep often improves in the first two weeks, and the earliest waist change in people who respond shows between weeks 8 and 12. About 3 in 10 people in the trials did not respond. If your waist has not changed by week 26, your prescriber will talk with you about stopping. If you stop, visceral fat tends to come back.
Who should not take tesamorelin?
Do not use tesamorelin with active cancer, a pituitary tumor, or during pregnancy. It is prohibited at all times in tested sport under WADA rules. Tell your prescriber about diabetes or prediabetes, carpal tunnel symptoms, or joint problems. If you have diabetes or prediabetes, send a recent HbA1c or fasting glucose from your own doctor before your first fill. We do not order lab work, and everyone else starts without a test. Joint pain, swelling in the hands or feet, tingling or numbness in the hands, rising home glucose readings, or injection-site redness usually mean the dose should come down, not that the drug should stop. Message your provider in the portal. Your prescriber can lower the dose, and the label states the units for the vial you have.
Where do I inject tesamorelin?
Under the skin of the abdomen, rotating sites with each injection, using a U-100 insulin syringe (a 0.3 mL barrel reads a draw of up to 30 units most accurately; a 33-unit draw is more than a 0.3 mL barrel holds and needs a larger one). Inject at bedtime. The trials allowed any time of day, so doing it every scheduled night matters more than the exact hour.
How is tesamorelin supplied and stored?
Compounded by a licensed U.S. 503A compounding pharmacy under a patient-specific prescription. Ships pre-reconstituted and ready to inject in cold-chain packaging. Every batch is tested by Eagle Analytical Services for sterility and bacterial endotoxin; the Certificate of Analysis is published on this product page. Keep vials in the refrigerator (36 to 46 °F), away from light, never frozen.

Ready to add Tesamorelin High-Dose?

A licensed provider reviews every order.